Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver ... (cancerand more than 52000 people are exp...)

HOME >> MEDICINE >> TECHNOLOGY

Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases

Date:3/20/2008

cancer, and more than 52,000 people are expected to die from it in the U.S. this year.

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Forward Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future events, operations, products and services, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans" and similar expressions. Although sanofi-aventis' management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include those discussed or identified in the public filings with the SEC and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Lookin
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
4. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
5. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
6. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
7. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
8. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
9. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
10. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
11. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes

Post Your Comments:

(Date:12/15/2009)... At today,s regular meeting of the board of directors ... the board declared a regular quarterly dividend of 31 ... of record at the close of business on February ... ,, The Lubrizol Corporation (NYSE: LZ ) ... supplies technologies that improve the quality and performance of ...

(Date:12/15/2009)... Ind., Dec. 15 Today, Hill-Rom Holdings, ... investors regarding progress on significant strategic and financial ... City. The Conference is hosted by Peter ... will include presentations on the following topics: ,, ... unit, research and development and financial updates ...

(Date:12/15/2009)... HAVEN, Conn., Dec. 15 Rib-X Pharmaceuticals, ... and commercialization of novel drugs for the treatment ... entered into a collaborative research agreement with Massachusetts ... science plan for the collaboration, Dr. David Hooper ... in an established animal model to determine resistance ...

Breaking Medicine Technology:Lubrizol Declares Dividend 2 Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 2 Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 3 Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 4 Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 5 Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 6 Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 7 Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 2 Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 3 Innovative Biofeedback Technology Wins By A 26quot 3BKnockout 26quot 3B 62417 1 Innovative Biofeedback Technology Wins By A 26quot 3BKnockout 26quot 3B 62417 2 Innovative Biofeedback Technology Wins By A 26quot 3BKnockout 26quot 3B 62417 3 Innovative Biofeedback Technology Wins By A 26quot 3BKnockout 26quot 3B 62417 4 Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification 62412 1 Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification 62412 2 Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty 62407 1 Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty 62407 2

[0] Lubrizol Declares Dividend [0] Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies [0] Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital

... Ambulatory BP MeasuresPARSIPPANY, N.J., May 8 Daiichi Sankyo, ... Society of Hypertension, Inc. (ASH) Twenty-Fourth Annual Scientific Meeting ... AZ OR(R) T rial E valuating ... ) demonstrated that a stepwise amlodipine and olmesartan medoxomil-based ...

... Inc. (Nasdaq: BNVI ) today announced first quarter ... 31, 2009. Company Highlights , ... on a preclinical anti-cancer drug candidate, BN108, at the American ... has been identified as an active compound of BN108 that ...

New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure Bionovo Announces First Quarter 2009 Highlights and Financial Results

(Date:12/15/2009)... Dec. 15 Hospira, Inc. (NYSE: ... in generic injectable pharmaceuticals, and Orchid Chemicals ... a leading Indian pharmaceuticals company and among ... today announced an agreement for Hospira to ... business for approximately $400 million. ,, ...

(Date:12/15/2009)... treated with hormones, but when the tumours start growing ... a thesis from the Sahlgrenska Academy, at the University ... new treatments for hormone-resistant prostate cancer. , Late in ... has spread, most patients are given hormone therapy. This ... the tumour shrinks. , "The problem is that the ...

(Date:12/15/2009)... international team of Canadian and Spanish scientists have found ... develop severe pneumonia when infected by the pandemic H1N1 ... regulating molecules for 20 hospitalized patients, 15 outpatients and ... first pandemic wave in July and August 2009. Researchers ... and the University Health Network found high levels of ...

(Date:12/15/2009)... users to control the volume without compromising sound-quality or comfort. ... ... 15, 2009 -- EarPeace ( www.earpeace.com ) is redefining hearing ... in three different skin-tone colors. "As a big fan of ... I was looking for a way to continue my active ...

(Date:12/15/2009)... Volume Injections Dangerous , ... New ... hype surrounding buttock augmentation and other large-volume body enhancing injections ... an alarming and potentially deadly trend, cautions the Physicians ... polymethylmethacrylate (PMMA), silicone, and polyacrylimide used in augmenting buttocks, hips, ...

Breaking Medicine News(10 mins):Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 2 Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 3 Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 4 Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 5 Health News:Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business 6 Health News:More blood vessels in hormone-resistant prostate tumors 2 Health News:First immunological clue to why some H1N1 patients get very ill or die 2 Health News:EarPeace Introduces Elegant, High-fidelity Hearing Protection Solution 2 Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 2 Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 3 Health News:Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly 4

[0] Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals Business [0] More blood vessels in hormone-resistant prostate tumors [0] First immunological clue to why some H1N1 patients get very ill or die [0] EarPeace Introduces Elegant, High-fidelity Hearing Protection Solution [0] Physicians Coalition for Injectable Safety Warns Buttock-Boosting Injections Risky and Deadly

... zero in on a DNA cluster that may encourage ... Mexican-Americans carrying what,s known as a haplotype of a ... a new study finds. , Haplotypes are clusters of ... the University of Kansas Medical Center (UKMC)collected blood samples ...

... 13 Allarae Healthcare,Inc. (Pink Sheets: ALHI) announced today ... to sell their entire product line on a,non-exclusive basis, ... health testing kits, several already FDA approved, and personal,tracking ... for market but have,not yet been commercialized., The ...

... WELLINGTON, Fla., Dec. 13 The Quantum Group,Inc. ... that it,has completed its registered public offering, raising ... that it has initiated trading,on the American Stock ... under the symbol "QGP.U." In addition, Quantum common ...

... Network Foundation for the Hospital,s ... State-of-the-Art Cardiothoracic Center, SANTA CLARA, ... completion of a new network,infrastructure to support a trust-wide ... Thurrock University Hospitals, part,of the NHS Foundation Trust in ...

... create new dental plan services for members, ... (GDS) /,Denex, provider of comprehensive dental plans and ... a division of the,nation,s leading integrated health plan ... processing, network access and,call center support to Kaiser ...

... Getting in shape shouldn,t feel like,getting your teeth ... veteran of the fitness industry. For anyone who,s vowed ... a novel fitness,program to help them get going. Recently ... people to "ease into," exercise,going at their own pace, ...

Other Medicine News:Health News:Genetics May Boost Mexican-Americans' Risk for Alcoholism 2 Health News:Allarae Healthcare Inc. Announces Signing of Distribution Agreement With Intellect Inc. 2 Health News:The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol 'QGP' 2 Health News:The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol 'QGP' 3 Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 2 Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 3 Health News:Fitness Guru Offers Novel Exercise Program and Tips to Stick with Exercise in the New Year 2

Genetics May Boost Mexican-Americans' Risk for Alcoholism Allarae Healthcare Inc. Announces Signing of Distribution Agreement With Intellect Inc.The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol 'QGP'Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital GDS / Denex Dental Selected by Kaiser Permanente Northwest Fitness Guru Offers Novel Exercise Program and Tips to Stick with Exercise in the New Year

... of 96 tips, Sterilized Diamond- Tips are ... Diamond Tips are irradiated by gamma-rays for ... a certificate of sterilization, specifying the date ... free of detectable Rnase, Dnase, DNA, RNA, ...

... to optimize the accuracy and precision of ... is widely recognized by customers throughout the ... over the years and now covers a ... including filter tips, certified pure tips, stepper ...

Designed to fit the Brinkmann Tranferpette and Treff Multi-Channel 300 L Pipettors, this tip provides extra space for repeat pipetting....

For the quantitative determination of luteinizing hormone (LH) concentration in human serum....

Medicine Products:

Tipack (Sterilized) D200 Finntip 50 MBP 300E Multi-Channel Luteinizing Hormone (LH) Enzyme Immunoassay Test Kit

Perioperative Eloxatin(R)-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver ...(cancerand more than 52000 people are exp...),Health